Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Health Outcomes in Rheumatoid Arthritis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2006 by Johns Hopkins University.
Recruitment status was:  Recruiting
Information provided by:
Johns Hopkins University Identifier:
First received: June 28, 2006
Last updated: NA
Last verified: May 2006
History: No changes posted
This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.

Rheumatoid Arthritis

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Health Outcomes in Rheumatoid Arthritis

Resource links provided by NLM:

Further study details as provided by Johns Hopkins University:

Estimated Enrollment: 260

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Males and females age 19 or older
  • Current active, adult-onset rheumatoid arthritis who meet ACR criteria for RA and have: (American College of Rheumatology [ACR] functional class I–III), defined as:
  • 3 or more swollen or tender joints and
  • Morning stiffness of 45min or longer
  • OR judged by their rheumatologist to have active disease
  • No evidence of other inflammatory diseases (e.g., Crohn’s, IBS)
  • Functional class I, II or III

Exclusion Criteria:

  • Individuals with significant cardiovascular disease (CHF, stroke, MI)
  • Unwilling to have medications monitored and/or comply with protocol
  • Not fluent in English
  • Planning to move from area within next year or change health insurance (which would preclude ongoing care by JH rheumatologist)
  • Enrolled in study evaluating efficacy of new or existing RA medications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00346411

Contact: Steffany Haaz, MFA (410) 550-5216
Contact: Susan Bartlett, PhD (410) 550-7775

United States, Maryland
Johns Hopkins Bayview Campus Recruiting
Baltimore, Maryland, United States, 21224
Contact: Steffany Haaz, MFA    410-550-5216   
Contact: Susan Bartlett, PhD    (410) 550-7775   
Principal Investigator: Susan Bartlett, PhD         
Good Samaritan Hospital Recruiting
Baltimore, Maryland, United States, 21239
Contact: Clifford Bingham, MD    410-532-4646   
Sub-Investigator: Clifford Bingham, MD         
Sponsors and Collaborators
Johns Hopkins University
Principal Investigator: Susan Bartlett, PhD Johns Hopkins School of Medicine
Study Director: Steffany Haaz, MFA Johns Hopkins University
  More Information Identifier: NCT00346411     History of Changes
Other Study ID Numbers: NA_00001359
Study First Received: June 28, 2006
Last Updated: June 28, 2006

Keywords provided by Johns Hopkins University:
rheumatoid arthritis

Additional relevant MeSH terms:
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases processed this record on May 25, 2017